BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 10446971)

  • 21. Ornithine decarboxylase expression in cutaneous papillomas in SENCAR mice is associated with altered expression of keratins 1 and 10.
    Sundberg JP; Erickson AA; Roop DR; Binder RL
    Cancer Res; 1994 Mar; 54(5):1344-51. PubMed ID: 7509717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis.
    Roop DR; Krieg TM; Mehrel T; Cheng CK; Yuspa SH
    Cancer Res; 1988 Jun; 48(11):3245-52. PubMed ID: 2452688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice.
    Arbeit JM; Olson DC; Hanahan D
    Oncogene; 1996 Nov; 13(9):1847-57. PubMed ID: 8934530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.
    Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR
    Oncogene; 1998 Jul; 17(1):35-45. PubMed ID: 9671312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal abnormalities and increased malignancy of skin tumors in human epidermal keratin 8-expressing transgenic mice.
    Casanova ML; Bravo A; Martínez-Palacio J; Fernández-Aceñero MJ; Villanueva C; Larcher F; Conti CJ; Jorcano JL
    FASEB J; 2004 Oct; 18(13):1556-8. PubMed ID: 15319370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe follicular hyperplasia and spontaneous papilloma formation in transgenic mice expressing the neu oncogene under the control of the bovine keratin 5 promoter.
    Bol D; Kiguchi K; Beltrán L; Rupp T; Moats S; Gimenez-Conti I; Jorcano J; DiGiovanni J
    Mol Carcinog; 1998 Jan; 21(1):2-12. PubMed ID: 9473766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice.
    Paul B; Hayes CS; Kim A; Athar M; Gilmour SK
    Carcinogenesis; 2005 Jan; 26(1):119-24. PubMed ID: 15375010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin.
    Smith MK; Trempus CS; Gilmour SK
    Carcinogenesis; 1998 Aug; 19(8):1409-15. PubMed ID: 9744537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8.
    Schaper ID; Marcuzzi GP; Weissenborn SJ; Kasper HU; Dries V; Smyth N; Fuchs P; Pfister H
    Cancer Res; 2005 Feb; 65(4):1394-400. PubMed ID: 15735026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis.
    Rossiter H; Beissert S; Mayer C; Schön MP; Wienrich BG; Tschachler E; Kupper TS
    Cancer Res; 2001 May; 61(9):3619-26. PubMed ID: 11325830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemopreventive effects of alpha-santalol on skin tumor development in CD-1 and SENCAR mice.
    Dwivedi C; Guan X; Harmsen WL; Voss AL; Goetz-Parten DE; Koopman EM; Johnson KM; Valluri HB; Matthees DP
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):151-6. PubMed ID: 12582025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-1 alpha, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1 alpha in epidermis on chemical carcinogenesis.
    Murphy JE; Morales RE; Scott J; Kupper TS
    J Immunol; 2003 Jun; 170(11):5697-703. PubMed ID: 12759452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplants.
    Carbone PP; Pirsch JD; Thomas JP; Douglas JA; Verma AK; Larson PO; Snow S; Tutsch KD; Pauk D
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):657-61. PubMed ID: 11401916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
    Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
    Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B.
    Chung WY; Park JH; Kim MJ; Kim HO; Hwang JK; Lee SK; Park KK
    Carcinogenesis; 2007 Jun; 28(6):1224-31. PubMed ID: 17234720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice.
    Arbeit JM; Münger K; Howley PM; Hanahan D
    J Virol; 1994 Jul; 68(7):4358-68. PubMed ID: 7515971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of Brassica oleraceae var capitata on epidermal glutathione and lipid peroxides in DMBA-initiated-TPA-promoted mice.
    Isbir T; Yaylim I; Aydin M; Oztürk O; Koyuncu H; Zeybek U; Ağaçhan B; Yilmaz H
    Anticancer Res; 2000; 20(1A):219-24. PubMed ID: 10769658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of ornithine decarboxylase activity is a necessary step for mitogen-activated protein kinase kinase-induced skin tumorigenesis.
    Feith DJ; Bol DK; Carboni JM; Lynch MJ; Sass-Kuhn S; Shoop PL; Shantz LM
    Cancer Res; 2005 Jan; 65(2):572-8. PubMed ID: 15695401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
    Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
    Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.